Karen Fallen has been appointed chief executive officer of Touchlight DNA Services Ltd, a biotechnology company focused on the discovery and development of DNA-based genetic medicines. Her responsibilities will include the expansion of the UK-based company’s contract manufacturing business, boosting manufacturing capacity, and extending the customer base globally. Ms Fallen joins from Lonza Pharma & Biotech where she was most recently president of mammalian and microbial development and manufacturing.
Touchlight announced the appointment on 15 October 2020.
Copyright 2020 Evernow Publishing Ltd